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Although demographic aging does not remain restricted to industrialized countries, the medical challenge arising from the
aging population will be distinct in the developing world. This is particularly true with respect to infectious diseases, which
have a distinct spectrum in the elderly population, as well as a greater overall relevance in the developing world. Tropical
diseases have a specific presentation and epidemiology in elderly patients. Infectious diseases with a worldwide distribution
impact elderly patients in the developing world in a specific manner, which is most obvious with respect to human immu-
nodeficiency virus and tuberculosis but is also true with respect to “trivial” manifestations of infection, such as diarrhea
and pneumonia. Malnutrition contributes in a major way to the immunodeficiency of elderly patients in the developing
world. Poorly controlled use of antimicrobial drugs leads to multidrug-resistant microorganisms, which, together with the
limited resources available for drug treatment, makes appropriate treatment of infections in elderly patients in developing
countries very difficult. Infections in elderly patients will have an increasing impact on the public health and economy of
developing countries.
Infections in elderly patients are a major medical problem. After
a period of neglect, this problem is now receiving the deserved
attention of the medical community [1–3]. Specific manifes-
tations of infectious diseases in the elderly population are ad-
dressed by several reports in the “Aging and Infectious Dis-
eases” section of Clinical Infectious Diseases. However, these
reports have almost exclusively focused on the situation in
industrialized countries, which differs substantially from that
in developing countries. In developing countries, different types
of pathogens are encountered, poverty and malnutrition lead
to amplified severity of commonly encountered infections,
transmission of pathogens is increased as a results of deficient
infrastructure (e.g., water supply, sewage system, and hospital
hygiene), and there is a lack of resources to treat the specific
medical needs of elderly patients. Thus, the problems associated
with infections in elderly patients and their impact on the med-
ical and socioeconomic systems in developing countries need
a specific assessment.
In this review, we address the following questions: demo-
graphic aging is now well established in industrialized countries
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[4], but to what extent will it occur in the developing world?
Are there specific manifestations of tropical infectious diseases
(such as malaria or leishmaniasis) in elderly patients? What is
the impact of ubiquitous infectious diseases such as tubercu-
losis, AIDS, and pneumonia on the elderly population? What
is the impact of malnutrition and dietary changes? And lastly,
what is the impact of these elements on society in developing
countries?
The information in this review has been gathered from Med-
line database searches and from data services provided by the
World Health Organization (WHO) and the United Nations.
In addition, data have been kindly provided by colleagues who
performed studies in developing countries.
AGING OF THE POPULATION IN DEVELOPING
COUNTRIES
Change in the demographic structure. Demographic aging
is now well established, and the elderly population (age, 165
years) will exceed 1 billion persons in 2030 [4]. To date, the
projection of population aging predicts that the proportion of
elderly individuals will be as great as 19.6% and 23.0% of the
population in North America and Europe, respectively, com-
pared with 4.6% in Africa and 11.5% in both Asia and Latin
America. However, these proportions are changing [5, 6], and
in 2030, more than three-quarters of the elderly population are
predicted to live in developing countries. This fast-changing
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pace in the demographic structure results from a phenomenon
called the “demographic transition,” in which the successive or
concomitant reduction in death and birth rates [5] results in
the former boosting population size and the latter increasing
the proportion of elderly individuals. At present, the increase
in the elderly population of developing countries is dramatically
faster than the increase observed in industrialized countries
(i.e., those in Europe, North America, Australia/New Zealand,
and Japan) [4], which has taken place over more than a century
[7]. Because aging is associated with a higher prevalence of
chronic and debilitating diseases leading to disability, health
care needs will increase among the aging population and will
place more pressure on the already constrained health care
resources of developing countries [8, 9].
Infectious diseases of major relevance. The demographic
transition is associated with an epidemiological transition in
the causes and age of death. A predominant feature of this
transition is a decrease in the number of deadly infections
occurring during childhood [10]. On the contrary, it is pro-
jected that, in 2020, three-quarters of all deaths in developing
countries could be due to age-associated diseases. These are
predominantly noncommunicable diseases, such ascardiovas-
cular disease, cancer, and diabetes. What is the role of infection
in the death of elderly individuals? Statistics from the WHO
[11] suggest that, in Europe and the United States, ∼5% of the
population 160 years old will die as a consequence of infection,
compared with ∼20% in Africa. However, although this relative
difference in the importance of infection as a cause of death
in industrialized countries versus developing countries is cer-
tainly relevant, the absolute numbers should be regarded with
caution. Indeed, although studies using death certificates to
identify causes of death usually find a relatively low importance
of infection in industrialized countries, autopsy studies suggest
a much higher contribution of infections to the overall causes
of death (20%–30%) [12]. In the developing world, the leading
infectious causes of death are respiratory tract infections, di-
arrheal diseases, tuberculosis, malaria, and AIDS, which to-
gether represent 190% of deaths [11]. The remaining 10% are
due to tropical diseases and various other infections [11]. In
industrialized countries, respiratory tract infections, blood-
stream infections, urinary tract infections, and infections of the
digestive system represent 90% of infection-related deaths;
other diseases such as tuberculosis, hepatitis B and C, diarrheal
diseases, and AIDS represent nearly all of the remaining 10%
[11]. As already stated by Kalache in 1996, many infectious
diseases “no longer kill but neither do they die” [7, pp. 22–
31]. This aphorism is also a reminder that the impact of in-
fectious diseases should not only be measured by mortality rate,
but also by morbidity and quality of life, particularly in the
aging population. These parameters are much more difficult to
assess objectively, but understanding them will be increasingly
important in the future.
TROPICAL INFECTIONS IN OLDER ADULTS
Little is known about the presentation of tropical disease in
elderly patients. Because many of these illnesses have been re-
emerging during the last decade, an understanding of their
specific manifestations in elderly patients is very important.
Malaria. Malaria is a major cause of morbidity and mor-
tality in developing countries [11]. Higher parasite loads [13]
and a higher proportion of severe forms (e.g., cerebral com-
plications, more-frequent fatal outcome) have been reported
to be associated with malaria among elderly individuals without
immunity, as compared with the younger adult population [14–
16]. The situation in areas of endemicity is more complex.
Because of the development of immunity, the incidence of fatal
disease decreases with age [17–19]; it occurs most commonly
in children !5 years old, is less frequent among adolescent
individuals, and is relatively rare among adults. However, ep-
idemiological reports now suggest an increase in fatal disease
in elderly individuals [11, 20]. From an immunological point
of view, this makes sense, because immune protection from
severe malaria needs continuous reactivation [17–19], sug-
gesting that it might not withstand age-associated loss of im-
mune function; moreover, a heightened Th1 response is
thought to be protective against malaria [19], and immuno-
senescence is characterized by a shift from a Th1 response to
a predominantly Th2 response [2, 21].
We are aware of only a single study [20] that addresses symp-
toms of malaria in elderly individuals with immunity. This
study analyzed elderly patients who were hospitalized for ma-
laria in the infectious diseases department of the Dakar Uni-
versity hospitals in Senegal. All cases were due to Plasmodium
falciparum infection. In these patients, asthenia, myalgia, and
coma were the 3 most common symptoms, found in 95%, 95%,
and 75% of the cases, respectively [20]. Note that fever was
observed in only 58% of the elderly patients. This contrasts
with results typically found in middle aged patients, among
whom the most commonly observed symptoms are fever (80%–
95%), asthenia (20%–30%), and myalgia (20%) [22, 23]. Coin-
fection (e.g., urinary tract infection and pneumonia) is com-
mon in elderly patients and was observed in 40% [20],
compared with 20%–30% of middle-aged patients [22]. Overall
mortality in these elderly patients from Dakar was 32% [20],
which is higher than the mortality rate associated with severe
malaria in the middle-aged patient population (10%–25%) [22,
23]. Of interest, elderly patients who did not fulfill established
criteria of malaria severity [23] also had a very high mortality
rate [20].
Taken together, these data show that P. falciparum infection
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Figure 1. Deaths per 1000 population per year, by age group, within
a 10-year period (1991–2001) in Malawi [42]. Note the dramatic impact
of HIV infection on all age groups and particularly on the population 150
years of age. HIV+, HIV-positive patients; HIV, HIV-negative patients.
is very severe in elderly patients with immunity. The reasons
for this are certainly complex and need further studies.
Leishmaniasis. Similar to other parasitic infections, vis-
ceral leishmaniasis (also known as kala-azar) is a re-emerging
disease [24]. The annual estimates for the worldwide incidence
and prevalence of this disease are 0.5 million and 2.5 million,
respectively [11]. Kala-azar is clustered in eastern Africa, north-
eastern India, and South America [24], where it accounts for
∼1 of every 1000 deaths due to infectious disease [11]. These
relative numbers are the same for both young and old adults
[11]. Thus, at present, kala-azar is not a problem that is par-
ticularly prevalent in the elderly population. However, this sit-
uation might change. Indeed, it is now clearly established that
latent infection with Leishmania exists, as illustrated by the
reactivation of Leishmania in patients with HIV infection [25,
26] and transplant recipients [27]. In a manner similar to that
of latent Mycobacterium tuberculosis infection, survival of Leish-
mania amastigotes occurs within macrophages [12]. The rate
of positive Leishmania skin test results among the elderly pop-
ulation in affected countries is high: 30%, 60%, and 70% in
India, Brazil, and The Sudan, respectively [24, 28, 29]. Thus,
even if only 1% of elderly individuals eventually experience a
reactivation of leishmaniasis, this infection might become a
relevant geriatric problem in affected countries.
Helminthiasis. In recent years, numerous re-emerging hel-
minth zoonoses have been described [30], but, thus far, few of
them have been associated with the aging population. One
example that has been associated with this population is chronic
infection with the hookworm Necator americanus in China.
Symptoms of chronic disease depend on the worm burden and
have been described as anemia and hypoproteinemia [31]. The
prevalence of infection increases with age: from ∼20% in ad-
olescent individuals, to ∼50% in middle aged individuals, and
to 180% in very old individuals (age, 180 years) [32]. In ad-
dition, the egg count in the stool of infected persons increases
with age and is 1100-fold higher in very old individuals than
in adolescents [32]. Given the correlation between egg count
and chronic symptoms, it is likely that the high parasite density
observed in elderly individuals aggravates typical age-associated
problems such as anemia and hypoproteinemia [32].
SPECIFIC ASPECTS OF UBIQUITOUS
INFECTIONS
AIDS. The number of elderly patients with HIV infection is
increasing throughout the world [33–35]. In industrialized
countries, HIV-infected individuals aged50 years account for
10%–15% of HIV-infected individuals [33, 34], but seroprev-
alence in this age group remains relatively low (∼0.1%; M.
Gebhard [Federal Public Health Office, Bern, Switzerland] and
M. Rickenbach [University Hospital, Lausanne, Switzerland],
personal communication). In developing countries, elderly in-
dividuals represent a smaller fraction of HIV-infected individ-
uals (4.5%, 5.6%, and 7.6% in Asia, Africa, and Latin America,
respectively) [35–37], but HIV type 1 seroprevalence is often
much higher: for example, 2.5% of the elderly population in
rural villages of Cameroon [38] and 15% of the elderly pop-
ulation in Dar es Salaam (the capital of Tanzania) [39] have
been reported to be HIV positive. In some developing countries,
HIV infection is now one of the main causes of hospitalization
for people 155 years of age [36]. The main route of HIV in-
fection in the elderly population is heterosexual transmission;
transmission by men who have sex with men and injection
drug users plays only a minor role [36, 39, 40]. Nosocomial
HIV transmission also plays a role in developing countries [41]
but, to the best of our knowledge, no data are available for the
elderly population.
The main presenting features of HIV infection in elderly
Africans at hospitalization are wasting (40%–50%), fever (39%–
89%), weight loss (40%–100%), and diarrhea (30%–60%) [36,
38, 39]. One study reported a 10.5-month delay between the
onset of symptoms and hospital admission [36]. HIV-positive
elderly individuals in developing countries have a shorter sur-
vival than does the younger population [36, 37, 39]. Data from
Malawi, however, suggest that this increased mortality is, at
least in part, attributable to the age-related increase in overall
mortality (figure 1) [42]. Coinfections (including tuberculosis,
malaria, leishmaniasis, pneumonia, and diarrheal syndrome)
[43–45] might have an important impact on mortality in elderly
patients, but no data concerning this question are available.
The HIV pandemic not only affects the elderly population
through direct infection with the virus, but it also has a major
indirect impact. HIV increases the spread of pathogens in com-
munity and hospital settings. Given their decreased host de-
fense, elderly individuals are likely to be plagued by this sec-
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ondary wave of infections. Such an HIV-induced increase in
pathogen transmission has been documented for tuberculosis
[45] but may also apply to malaria, pneumonia, and other
infections [44–47].
Of the various consequences of the HIV pandemic, it is illness
and death among the younger generation as a result of HIV
infection that has possibly the most dramatic impact on the
elderly population in the developing world [35, 48, 49]. This
impact is on the level of emotional, economic, physical, and
social well-being [48–51]. The elderly population has to func-
tion as caregivers for their HIV-infected adult children and
guarantee the upbringing and education of their orphaned
grandchildren [35, 49]. To make things worse, as the burden
of HIV infection overwhelms the health care systems in the
developing world, health care provided to elderly patients de-
creases [48–50]. Thus, the HIV epidemic transforms the elderly
population into major care-providers and—at the same time—
deprives them of medical care. A recent study by the WHO
[49] concludes that, in HIV-plagued developing countries,
health care for the elderly population should be a priority,
because it is of primary importance for the sustainability of
the care that the elderly population provides.
Tuberculosis. In developing countries (in particular, those
located in sub-Saharan Africa and Asia), tuberculosis is much
more common than in industrialized countries. Although, in
industrialized countries, annual incidence rates of tuberculosis
show a slight decrease both in younger adults (age, 25–64 years)
and in elderly individuals (age, 165 years) [52], in developing
countries, the incidence of tuberculosis is still increasing [52,
53], and—at least in some countries—this increase affects the
elderly population preferentially (increases are 30%–300%
greater than in the younger population) [52].
As in industrialized countries [54, 55], the presentation of
tuberculosis in the elderly population of developing countries
is atypical, with more disseminated disease and more-frequent
lower lobe involvement in the case of pulmonary tuberculosis
[56, 57]. The time periods from the onset of symptoms to the
establishment of diagnosis are longer and outcomes are worse
than they are in the younger population [57–60].
In general, antituberculous treatment in elderly populations
is efficient and safe, but drug-induced hepatitis and inter-
actions with other drugs may be relevant problems [54]. In
most developing countries, antituberculous drugs, which are
relatively cheap, can be obtained. Instrumental to the distri-
bution of drugs (but also instrumental to increasing com-
pliance and avoiding resistance) is Directly Observed Therapy
Strategy (commonly known as DOTS) [53]. However, the
difficulties faced by the elderly population in obtaining access
to health care (e.g., limited financial sources, functional dis-
abilities, and remote living areas) may lead to an exclusion
from treatment, a situation that has already been documented
in India [57]. In Taiwan, rates of drug resistances have been
found in the elderly population that are higher than those in
the general population [59].
Diarrhea. Infectious diarrhea is one of the main causes
of morbidity and mortality in developing countries [11]. Caus-
ative microorganisms are numerous and include bacteria (e.g.,
Vibrio cholerae and Shigella, Salmonella, and Campylobacter spe-
cies), viruses (e.g., Noroviruses and Rotavirus) and protozoa
(e.g., Giarda and Cryptosporidium species) [61]. The varying
levels of prevalence reflect the level of hygiene and sanitation
in the respective areas [11, 62–64], and an increasing number
of studies [62, 65, 66] report diarrhea as a health problem in
the elderly population in developing countries. The World
Health Report 2002 [11] cites diarrhea as the second or third
most important cause of death due to infection among indi-
viduals 160 years of age in developing countries. Thus, although
often considered to be trivial, infectious diarrhea in elderly
patients is a very important health problem in the developing
world.
Influenza. Because of the lack of efficient surveillance pro-
grams in developing countries, it is difficult to assess the real
impact of influenza in elderly patients. However, studies of
several outbreaks in Taiwan and South Africa show that influ-
enza is associated with greater morbidity and mortality in eld-
erly patients than in the general population [67–69], and studies
from Argentina, Brazil, and China demonstrate the efficacy of
vaccination in the elderly population with respect to the pre-
vention of both influenza-like illness and pneumonia [70–72].
Common infections in the elderly population. In indus-
trialized countries, pneumonia, urinary tract infections, and
skin and soft-tissue infections are the most relevant infections
in elderly patients [2, 73, 74]. In developing countries, the
incidence of these infections is comparably high. Thus, tropical
infections do not replace common infections in the developing
world but are superimposed on the infectious problems that
are seen in elderly individuals in the industrialized world. In
developing countries, pneumonia is one of the leading causes
of death in elderly patients (those 160 years of age) [11]. In
South Africa, invasive pneumococcal disease is 3-fold higher
in the elderly population than in the younger population [43],
and the mortality rate is higher, as well [75–78] (OR, 1.5 per
decade [77]). The prevalence of meningitis is high among eld-
erly Senegalese, compared with the general adult population of
Senegal [66, 79]. Meningitis is the fourth-most common in-
fectious pathology requiring hospitalization [66] and is also
associated with poor outcome [66, 79]. Studies from South
America, India, and Africa investigating the global impact of
infections in elderly patients conclude that, compared with the
younger population, elderly patients with an infectious disease
are hospitalized more often and have a higher mortality rate,
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Table 1. Ciprofloxacin resistance in urinary
tract infection of Argentinian outpatients, 2000–
2003.
Ciprofloxacin-resistant
isolates, by patient
age in years
Bacterium !65 165
Escherichia coli 461 (7.3) 325 (21.3)
Proteus mirabilis 45 (4.5) 32 (25.0)
Klebsiella pneumoniae 31 (6.6) 31 (19.3)
NOTE. Data are no. of ciprofloxin-resistant isolates (%
of isolates). Data were provided by C. Bantar (Hospital San
Martı´n, Parana´, Entre Rı´os, Argentina).
a longer duration of hospital stay, and a higher risk of secondary
disability [74–80].
The limited data available on nosocomial infections in de-
veloping countries suggest that, as in industrialized countries
[81, 82], elderly patients in developing countries are more likely
to acquire infections during hospitalization [83, 84]. The de-
ficiency of hospital infection-control practices enhances the
magnitude of the problem in the developing world [84–86].
Emerging infectious diseases. Emerging infectious diseases
are mostly thought of in the context of the younger population.
However, this picture is incomplete, and numerous emerging
infections may be associated with a higher prevalence and a
distinct clinical presentation in the elderly population. For ex-
ample, during an outbreak of West Nile virus infection in New
York City, 73% of individuals with clinically apparent disease
were 160 years of age, and the relative risk for individuals 180
years of age to acquire the disease was 50 times greater than
that for young adults [87, 88]. During a West Nile virus in-
fection outbreak in Israel, 64% of hospitalized patients were
164 years old, and all patients with fatal cases were 177 years
old [87, 88]. A study of Dengue fever in Puerto Rico [89]
showed that infected individuals 164 years old had a greater
risk for hospitalization and death but—of interest—a decreased
risk for hemorrhage.
NUTRITION AND INFECTION
IN OLDER ADULTS
The immunodeficiency of elderly individuals is often attributed
to immunosenescence and is thus considered irreversible. How-
ever, malnutrition (energy, protein, and micronutrient defi-
ciency), which is found in 5%–10% of community-dwelling
elderly individuals but is also found in 30%–60% of hospital-
ized elderly patients in industrialized countries, is probably at
least as important a factor as is the aging of the immune system
[90, 91]. In developing countries, malnutrition in elderly in-
dividuals is even more common; for example, in Africa, where
150% of elderly households are in food poverty [92], 9.5%–
46.8% of the community-dwelling elderly population (age,60
years) have a body mass index of !18.5 kg/m2. For comparison,
only 6.1% of the community-dwelling elderly population (60
years of age) in Switzerland have a body mass index of !20
kg/m2 [92–95].
Paradoxically, malnutrition increasingly coexists with obesity
in the developing world. Economic development and urbani-
zation have led to a rapid change in dietary customs, with an
increased intake of fats, animal products, and refined foods and
a decreased intake of fresh vegetables and fibers [95]. This
phenomenon, called the “nutrition transition,” leads to higher
rates of obesity and chronic disease [95]. This, in turn, will
increase the risk of infection in elderly individuals, because
obesity leads to chronic diseases such as diabetes mellitus and
diverticulosis, which bring an increased risk of infection, and
because qualitative malnutrition enhances the immunodefi-
ciency of elderly individuals [95].
ANTIMICROBIAL DRUGS AND MICROBIAL
RESISTANCE
Numerous studies from developing countries show increasing
rates of bacterial resistance [86, 96]. Resistant microorganisms
relevant for community- and hospital-acquired infections in-
clude Neisseria meningitidis, Salmonella species, Streptococcus
pneumoniae, M. tuberculosis, methicillin-resistant Staphylococ-
cus aureus, Escherichia coli, and P. falciparum [64, 86, 96, 97].
The impact of this resistance development on the elderly pop-
ulation is now increasingly studied [83–86]. As an example, C.
Bantar (Committee for Prevention and Control of Nosocomial
Infections, Hospital San Martı´n, Parana´, Entre Rı´os, Argentina)
provided us with some unpublished data on Argentinean out-
patients presenting with urinary tract infection. This data shows
higher rates of ciprofloxacin resistance for E. coli, Proteus mir-
abilis, and Klebsiella pneumoniae in patients 65 years of age,
compared with younger patients (table 1). Reasons for the in-
creased development of antibiotic resistance in the elderly pop-
ulation of developing countries are numerous [2, 86, 96].
PUBLIC HEALTH AND SOCIOECONOMIC
IMPACT
Clearly, the aging of the population in developing countries
will increase the number of infectious episodes simply because
of the increased susceptibility of elderly individuals to infectious
agents. Will these elderly patients with infections also represent
a reservoir that, in turn, leads to increased transmission to the
younger population? At first consideration, this appears rather
unlikely, because the elderly population has a lower mobility
and a decreased risk of sexual transmission. However, the pos-
sibility has to be considered seriously. Taking the example of
methicillin-resistant S. aureus, nursing homes and long-term
care institutions are major reservoirs for the efficient propa-
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Figure 2. Impact of infectious disease in the elderly population on health care services (solid arrows) and factors contributing to an increase in
the burden of infectious disease in elderly individuals (patterned arrows). These circumstances create a vicious circle, limiting resources.
gation of this multidrug-resistant organism [83–85, 98].
Changes in the socioeconomic environment are likely to lead
to increased rates of institutionalization of elderly individuals
in developing countries [99]. Such an institutionalization of
elderly individuals will not only lead to major costs for society
but will create a major platform for nosocomial transmission.
In the developing world, this might even be relevant with re-
spect to nosocomial transmission of certain emerging infec-
tions. However, community-dwelling elderly individuals with
infections might also contribute to increased transmission of
pathogens. Diarrheal diseases are frequent in elderly individuals
in developing countries and can be readily transmitted [62, 65,
66]. A decrease in the success rate of antituberculosis treatment
in the elderly population might lead to an increased rate of
tuberculosis transmission, possibly even involving drug-resis-
tant mycobacteria [57].
From what we have described thus far, it is clear that infec-
tions in elderly individuals will substantially increase the societal
costs in developing countries during the next decades. Socio-
cultural factors, such as urban migration and the rupture of
both traditional family bonds and common cultural beliefs, are
also involved in increasing both the burden of infection [86,
100] and the social isolation of elderly individuals [86]. Only
a few developing countries apply social security schemes, forc-
ing elderly individuals to rely on family care [6, 99], which is
eroding because of poverty, continuing urbanization, and the
growing participation of women in the workforce [6, 99]. Thus,
costs for medical care and for nursing homes will increase. As
the financial resources required for proper health care of elderly
individuals are often not available, infections may go untreated,
which will enhance the magnitude of the problem through
reverse transmission from the infected elderly population to
the uninfected younger population and through the decreased
capacity of elderly individuals to function as socially relevant
caretakers. A vicious cycle is established: the increased medical
needs of the elderly population cannot be met because of lim-
ited and misused resources, and insufficient health care for
elderly individuals will lead to a further increase in health care
costs for the general population (figure 2).
There is no simple solution for the problems related to in-
fectious disease in the aging population of developing countries
[86, 101, 102]. Infection-control programs have been imple-
mented with some degree of success [103], but they usually do
not consider specifics with respect to the elderly population,
and they invariably lack long-term impact if they are not ac-
companied by broader socioeconomic measures [49, 86]. Tar-
gets for such broader measures include hygiene, water and food
sanitation [86, 96, 104], veterinary surveillance, control of drug
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sales (i.e., the number of prescriptions and the quality of the
drugs), and many other factors.
PERSPECTIVE
In developing countries, the aging of the population structure
will be faster than that which occurred during the previous
century in industrialized countries. Such a rapidly aging pop-
ulation in countries with limited financial resources will raise
a multitude of problems. Health problems—and in particular
those associated with infectious disease—are only one element
in this complex situation. But, as was sadly demonstrated by
the AIDS epidemic, medical problems can overwhelm and de-
stroy all other aspects of society.
We would, however, like to emphasize that the aging of the
population in developing countries should not be viewed as
a problem per se. On the contrary, the increasing population
of elderly individuals represents a formidable chance for the
preservation and transmission of knowledge and competence
to younger generations. In 1962, the Malian writer Amadou
Hampate Baˆ said a sentence that has become a famous quote:
“When an old man dies, a library burns down” [105]. Today,
elderly individuals are probably saving the society in AIDS-
ridden sub-Saharan Africa. Thus, taking care of the needs of
elderly individuals in developing countries is not simply a
gesture of charity but is, rather, an imperative for survival
and development.
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